非小细胞肺癌患者EGFR检测的临床意义分析(2)
[3] 薛丽,白玉杰.EGFR基因突变与肿瘤靶向治疗[J].中国现代应用药学,2012,29(4):311-314.
[4] 王沣,操乐杰.晚期非小细胞肺癌患者体液标本表皮生长因子受体突变基因检测的进展[J].中华肺部疾病杂志,2012,5(4):380-384.
[5] 张琨琨,辇伟奇.肿瘤基因检测与分子靶向治疗[J].检验医学与临床,2012,9(22):2871-2873.
[6] Deluca A,Piqnata S,Casamassimi A,et al.De tection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay[J].Clin Cancer Res,2000,6(4):1439-1444.
[7] Clarke LE,Leitzel K,Smith J,et al.Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic,lung,and colon carcinomas detected by RTPCR[J].Int J Oncol,2003,22(2):425-430.
[8] 宋萍,李坚,郑金旭,等.外周血表皮生长因子受体和LUNX mRNA表达对肺癌微转移诊断的价值[J].南京医科大学学报(自然科学版),2008,28(2):173-176.
[9] Zheng H,Saito H,Masuda S,et al.Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas[J].Anticancer Res,2007,27(5B):3561-3569.
[10] 孙晓军,李杰.非小细胞肺癌患者血浆表皮生长因子受体基因突变检测及其临床意义[J].中华临床医师杂志(电子版),2013,7(7):2833-2837.
(收稿日期:2014-09-30 本文编辑:李亚聪) (农巧红 申东兰 牟尚东)
[4] 王沣,操乐杰.晚期非小细胞肺癌患者体液标本表皮生长因子受体突变基因检测的进展[J].中华肺部疾病杂志,2012,5(4):380-384.
[5] 张琨琨,辇伟奇.肿瘤基因检测与分子靶向治疗[J].检验医学与临床,2012,9(22):2871-2873.
[6] Deluca A,Piqnata S,Casamassimi A,et al.De tection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay[J].Clin Cancer Res,2000,6(4):1439-1444.
[7] Clarke LE,Leitzel K,Smith J,et al.Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic,lung,and colon carcinomas detected by RTPCR[J].Int J Oncol,2003,22(2):425-430.
[8] 宋萍,李坚,郑金旭,等.外周血表皮生长因子受体和LUNX mRNA表达对肺癌微转移诊断的价值[J].南京医科大学学报(自然科学版),2008,28(2):173-176.
[9] Zheng H,Saito H,Masuda S,et al.Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas[J].Anticancer Res,2007,27(5B):3561-3569.
[10] 孙晓军,李杰.非小细胞肺癌患者血浆表皮生长因子受体基因突变检测及其临床意义[J].中华临床医师杂志(电子版),2013,7(7):2833-2837.
(收稿日期:2014-09-30 本文编辑:李亚聪) (农巧红 申东兰 牟尚东)